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1. Introduction
The aim of this book chapter is to highlight the fact that regenerative medicine and tissue
engineering have important consequences for animal research and can be exploited to develop
powerful animal sparing in vitro models. The main objective of the authors is to encourage
researchers to consider designing, developing, utilizing and exploiting biomimetic alternatives
to in vivo animal models. This chapter will focus on some of the most popular in vitro models
that have been developed for skeletal muscle and articular cartilage. Refining these animal-
sparing models will advance tissue engineering and regenerative medicine and may replace
animal models and significantly reduce our dependence on animals in research. Over the last
few decades, a number of different animal models have been developed to support preclinical
and clinical research to address hypothesis or curiosity driven research. However, many of the
currently available animal models are not suitable models for human disease. 'Evidence-based
medicine' refers to the ability to locate, critically appraise and incorporate evidence into clinical
practice. This important branch of medicine seeks to assess the strength of evidence of the risks
and benefits of treatment (or lack of treatment) and relies on well-established and reliable
models to facilitate the research that underpins the decision-making process. Clinical research
and evidence-based medicine therefore rely on the availability of reliable model systems that
can be used for translational research. Using in vitro culture models eliminates some but not
all of the problems associated with clinical research with human subjects and animal models
of disease. In many cases culture models help to overcome barriers and allow researchers to
gain a better understanding of disease pathogenesis, characteristics and responses to treat‐
ments. This chapter will focus exclusively on animal sparing in vitro models of muscle and
joint tissues that have been developed to mimic these musculoskeletal structures. Many of
these models are well established and possess similar morphological, histological, biochemical
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and molecular characteristics of muscle and joint tissues in vivo. These in vitro models allow
researchers to perform original, hypothesis-or curiosity-driven research without using animals
while still accurately mimicking musculoskeletal tissues in real life. In vitro models also enable
screening for new drugs to treat musculoskeletal diseases in a more efficient and cost-effective
way such that real progress is achieved more quickly.
2. Biomimetic models
Tissue engineering is an interdisciplinary field that applies the principles of biology and
engineering to the development of functional substitutes for damaged tissue [1]. The loss or
failure of an organ or tissue is one of the most frequent, devastating, and costly problems in
human health care. By applying the basic principles of engineering and cell biology tissue
engineering is helping us to move toward the development of biological substitutes that
restore, maintain, or improve tissue function or a whole organ [2]. The new tissues can be used
as test beds in basic research and development and have potential for future use in transplan‐
tation and reconstructive surgery [3].
Biomimetics is defined as the study of the structure and function of biological systems as
models for the design and engineering of biomaterials. The term biomimetics was coined by
Otto Schmitt in the 1950s for the transfer of ideas and analogues from biology to technology
[4]. It generally refers to human-made and engineered processes, substances, devices, or
systems that imitate and therefore mimic natural processes and biological systems. It extends
to the study of the formation, structure and function of biological substances and materials
(i.e. enzymes, polymers, surfaces) and biological mechanisms or processes (i.e. catalysis,
protein synthesis) aimed at synthesizing similar products by artificial mechanisms that mimic
natural ones. Therefore, a biomimetic model aims to mimic the structure and function of a
biological system in its structure or function.
Organ, tissue and cell culture have been used for decades as biomimetic models of cells, tissues
and organs. The pioneering work of eminent scientists such as Sydney Ringer, Wilhelm Roux
and Ross Harrison from 1880 to the early 1900s helped to establish the principles and meth‐
odology of tissue culture. Ringer developed salt solutions containing the chlorides of sodium,
potassium, calcium and magnesium suitable for developing organ culture. He used this model
to maintain the beating of an isolated animal heart outside of the body. Roux maintained a
portion of the medullary plate of an embryonic chicken in a warm saline solution for several
days, establishing the principle of tissue culture. Harrison published the first paper that
successfully introduced tissue culture to settle the argument of how nerve fibres originated [5].
Although other scientists had examined cells in vitro several decades earlier, none of them had
successfully manage to culture them and it was Harrison who first successfully overcame basic
culture problems and created a technique that other investigators could follow [6]. The first
permanent fibroblast-like cell line was developed by Earle in 1943 from subcutaneous mouse
tissue [7]. This allowed the development of techniques for generating the first human "trans‐
formed" cell line, the HeLa cell, derived from a cervical carcinoma [8]. This resulted in the
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advent of cell and tissue culture. This technique is arguably one of the best and earliest
examples of biomimetics and has become one of the foundations of modern biomedical
research. It has been used for decades to grow tissues and cells isolated from living organisms.
Tissue culture generally refers to the growth of human or animal cells in vitro. However, the
term tissue culture can also be used to refer to the culturing of pieces of tissue, i.e. explants or
whole organs in culture. It is an invaluable tool for the study of cell biology and pathology.
Organ, tissue and cell culture are powerful reductionist techniques that have allowed us to
study the function of biological systems. However, they are not suitable models for every type
of biological question. For example results from cell culture are often not comparable to those
derived from in vivo studies using whole animals e.g. in studies of drug action and metabolism
since the drugs are metabolized in vivo but not in vitro. Furthermore, primary or derived culture
is rarely able to accurately model the physiological functions of an organ because of the
difficulties associated with re-creating neural, circulatory and endocrine signals in vitro.
Nevertheless, tissue culture remains a powerful technique and has many animal sparing
applications.
3. Biomimetic models and their potential for replacing, refining and
reducing laboratory animal models in research
The National Centre for the Replacement, Refinement and Reduction of Animals in Research
(NC3Rs) based in London, UK recently carried out some research to demonstrate that poor or
incomplete reporting of studies that use animals have made it difficult to derive the maximum
scientific knowledge from animal research. In addition, over the last few decades many
research laboratories in academia and industry have used laboratory animals unnecessarily.
A survey published by the National Institutes of Health (NIH) Office of Laboratory Animal
Welfare (OLAW)1, and the UK’s National Centre for the Replacement, Refinement and
Reduction of Animals in Research (NC3Rs2) has demonstrated that many peer-reviewed
scientific publications reporting publicly funded animal research from the UK and US lacked
key information on how the study was designed, conducted and analysed, which could limit
their value in informing future scientific studies and policy. In response to these findings the
NC3Rs has recently published the ARRIVE (Animal Research: Reporting In Vivo Experiments)
guidelines [9], which were specifically introduced to improve reporting of animal experiments.
These new guidelines have been published in PLoS Biology and several other prestigious
scientific journals. Many biomedical research organisations and international scientific
societies have already begun to implement these guidelines. The guidelines were developed
by the NC3Rs to improve standards of reporting and ensure that the data from animal
experiments can be fully evaluated and utilised. The ARRIVE guidelines consist of a 20-point
checklist of the essential information that should be included in publications reporting animal
1 http://grants.nih.gov/grants/olaw/
2 http://www.nc3rs.org.uk/
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research. Developed in consultation with the scientific community, including researchers,
statisticians, journal editors, and funders, the guidelines request essential information that
should be included in publications reporting animal research. Essentially the guidelines are
intended to improve reporting of research using animals; guide authors as to the essential
information to include in a manuscript, and not be absolutely prescriptive; be flexible to
accommodate reporting a wide range of research areas and experimental protocols; promote
reproducible, transparent, accurate, comprehensive, concise, logically ordered, well written
manuscripts and improve the communication of the research findings to the broader scientific
community. The UK's major bioscience funding bodies, including the Medical Research
Council, the Biotechnology and Biological Sciences Research Council, Department for Envi‐
ronment, Food and Rural Affairs (Defra3), the Natural Environment Research Council
(NERC4), the European Research Council (ERC5) and the Wellcome Trust6, have all incorpo‐
rated adherence to the guidelines into a revised version of 'Responsibility in the use of animals
in bioscience research: Expectations of the major research council and charitable funding
bodies', which was originally published in May 2008.
Although the ARRIVE guidelines are primarily aimed at scientists writing up their research
for publication and for those who are involved in peer review and intended to improve
standards of reporting data from animal experiments, they have also highlighted the potential
of biomimetic and tissue engineered in vitro models for replacing, refining and reducing the
use of laboratory animals in research.
4. Biomimetic models of muscle
Cells - Skeletal muscle cells can be cultured in vitro following their isolation from muscle tissue.
The main advantage of in vitro cultures of skeletal muscle precursor cells (MPCs) is the faithful
recapitulation of the events that occur in vivo during development and regeneration whereby
mononuclear MPCs fuse together under the correct conditions to form multinucleate myotubes
- essentially nascent muscle fibres. Skeletal muscle development occurs in the somites;
segments of paraxial mesoderm which form on either side of the neural tube [10], which is
further divided into the epaxial and hypaxial dermomyotome [11]. Cells in the dermomyotome
migrate and form the myotome, and transiently express the paired box transcription factors
Pax 3 and 7, and Muscle Regulatory Factors (MRFs) Myf5, MyoD and Myogenin [12], which
regulate myotube formation. The expression of these transcription factors has been shown to
be critical for 'normal' muscle formation during development [13, 14] and null mutations of
some of these genes can be lethal during the early post-natal period [15, 16]. Whilst the
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dermomyotome to the limb bud where they form the musculature of the limbs [10] under the
influence of MRFs.
A subset of Pax 7/3+ cells have been identified in the limb buds and myotome in development,
but fail to differentiate to form myotubes [17]. These proliferating precursor cells can adopt a
position between the developed myofibre and the basal lamina during later muscle develop‐
ment [17, 18], which strongly indicates that this subset of progenitors form the satellite cells of
post-natal skeletal muscle.
Satellite cells are the resident stem cells of skeletal muscle tissue, which provide additional
nuclei to a muscle fibre during regeneration, such as may occur following muscle injury,
damage or overload. Myonuclear addition is important in order for the muscle to effectively
synthesise new proteins and thus adapt to specific stimuli, as well as generally maintain and
increase its mass. Satellite cells are so called due to their anatomical location between the
sarcolemma and basal lamina of a muscle fibre [19], and this parameter was for some time the
only true 'marker' of these cells, achievable via electron microscopy. More recently however,
a host of proteins which are expressed by satellite cells have been identified, including Pax 7
[20], Caveolin-1 [21] and myf-5 [22], and thus a molecular signature of these cells is being
derived.
Satellite cells lie quiescent on the muscle periphery until becoming activated upon muscle
damage/overload. The precise cause of satellite cell activation remain elusive7. However the
fact that muscle injury leads to activation suggests that muscle damage itself may be the trigger
or a factor secreted from the muscle may provide the initial cue [23]. The latter notion has
support from the fact that Insulin Like Growth Factor-I (IGF-I) and indeed Hepatocyte Growth
Factor (HGF) are released from the muscle following mechanical use or injury [24-29] and have
been shown to activate satellite cells when exogenously administered [30-35]. Once activated,
satellite cells proliferate extensively and express the transcription factors myf-5 and MyoD [36]
as well as proteins specific to the myogenic lineage such as Desmin, before fusing with the
damaged/overloaded fibres under the influence of myogenin [37] to provide additional
myonuclei. As stem cells, satellite cells have the ability to self-renew and replenish the pool of
quiescent cells following activation. The literature suggests that asymmetric distribution of a
number of potential proteins is implicated in regulating self-renewal [38-40], causing some
daughter cells to express pax 7 and MyoD, and thus commit to the myogenic lineage and
undergo fusion, whereas a small portion fail to express MyoD or myf-5 and thus repopulate
the satellite cell pool [38, 39, 41].
Isolation and subsequent culture of MPCs (satellite cells when in their anatomical niche) can
be conducted either by explant culture, whereby muscle tissue is minced and maintained in
culture until MPCs migrate from the tissue [42, 43], or via enzymatic digestion, whereby the
tissue is broken down completely to release all of the resident mononuclear cells [44, 45].
Following isolation, careful consideration of the culture techniques should be taken in order
to standardise/optimise the desired experiments. Indeed, MPCs are sensitive to the media
7 Neil R.W. Martin and Mark P. Lewis.Satellite cell activation and number following acute and chronic exercise: A mini
review. Cellular and Molecular Exercise Physiology 1[1]: e3. doi:10.7457/cmep.v1i1.e3
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composition, and will either proliferate or exit the cell cycle and differentiate when exposed
to various media compositions [46]. Furthermore, MPCs are sensitive to environmental factors,
and will proliferate and fail to differentiate when exposed to low oxygen levels [47, 48] and
similarly, serial passaging of MPCs also appears to negatively effect their ability to differentiate
[49]. Finally, as the population of cells released from skeletal muscle tissue tends to be mixed
in nature (e.g. MPCs, fibroblasts, pericytes, endothelial cells etc.), it is often favourable to
further purify the MPCs prior to experimentation either via differential adhesion methods or
magnetic separation, a methodology optimise in our laboratory [50], however these cells may
contribute to the development of more biomimetic tissue (detailed in Figure 1 below).
Figure 1. Skeletal muscle precursor cells can be isolated and cultured in vitro to recapitulate the events of develop‐
ment and regeneration. (A). Phase contrast photomicrograph of human skeletal muscle explant with MPCs migrating
away from the tissue. (B) Immunostaining for Desmin (green) highlights those cells, which are commited to the myo‐
genic lineage. (C) Desmin positive cells form multinucleate myotubes when stimulated to do so. Scale bars = 100µm.
The isolation and characterisation of cells for utilisation in the development of in vitro skeletal
muscle models is an important stage in the engineering process. However, the consideration
of the influence of environmental factors in the creation of a biomimetic model is a necessity
and will be explored below.
Environment - The skeletal muscle cell microenvironment (commonly referred to as the niche)
supports the development of multi-nucleate myotubes (muscle fibres) in a number of ways:
provision of directional cues, provision of topographical cues, availability of growth factors,
transmission of mechanical signals and interactions with other cell types. Initial evidence that
particular proteins within the skeletal muscle cell niche play critical roles in these processes
and hence subsequent success of in vitro muscle cell behaviour, came with the establishment
of the varying effects of ECM molecules on MPC proliferation and differentiation. Extracting
bioactive ECM proteins from skeletal muscle for use as a growth substrate with in vitro MPC
culture, results in superior proliferation and differentiation compared to standard growth
substrates [51]. It is however the identification of interactions between ECM proteins and
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muscle cell surface proteins that has provided data regarding the requirements for successful
in vitro culture of MPCs.
Particularly, integrins and proteins of the Dystrophin Associated Protein (DAP) complex have
been demonstrated to play significant roles in MPC-ECM interaction in vitro. Indeed, the
expression of α v, α v β 3 and α v β 5 integrins is evident in MPCs seeded on ECM substrates
such as gelatin, fibronectin and vitronectin [52]. Moreover, blockade of α v integrin using a
specific antibody abolishes cell migratory capacity on fibronectin and vitronectin substrates
[52]. The effect of ECM matrix components has also been demonstrated to influence the
contractile phenotype of engineered skeletal muscle constructs. Increasing the content of ECM
protein rich Matrigel, contributed to greater peak force of engineered constructs, whilst
utilising growth factor reduced Matrigel did not affect the results [53]. This suggests that ECM
matrix composition contributes to skeletal muscle maturation and phenotype to a greater
extent than growth factors. These data provide clear evidence as to the importance of the ECM
in the successful culture of MPCs in vitro.
The primary function of skeletal muscle in vivo is to provide vector force, for the controlled
movement of the skeleton [54]. This directionality is achieved by the highly organised macro
and microstructure of the skeletal muscle fibres and the surrounding ECM8. The recapitulation
of this organised structure has been achieved through a variety of methodologies in vitro,
including the use of both synthetic [55-58] and naturally derived polymers [45, 59-63]. These
methods have provided both directional and topographical cellular cues, display varying
amounts of resemblance and functionality to in vivo tissue. It has been suggested however, that
the rigidity of synthetic polymers may affect the contractile properties and function of
developed myotubes, whilst if the polymer is bio-degradable the alignment of cells may be
affected by this process [64]. The use of naturally derived polymers (including fibrin and
collagen) has in part been shown to overcome these issues. Particularly in a more biomimetic
three-dimensional (3-D) structure, the rapid polymerisation of collagen matrices allows for an
even distribution of the cells seeded, whilst the nanostructure allows for multiple attachment
sites for the cells [64].
The provision of mechanical signals for the alignment and fusion of MPCs is an essential criterion
for developing biomimetic constructs in vitro, since skeletal muscle in vivo is under continuous
passive strain through the myotendinous junction. Such signals have been generated by the
polymerisation of a biological substrate to a fixed structure in a variety of in vitro skeletal muscle
models [45, 53, 65, 66]. The anchored structures provide the necessary passive lines of strain,
which provide the required signals to generate an orientated cellular architecture (See Figure 2
below). Indeed, it is clear that the 3-D structure and the presence of passive mechanical signals
promote the alignment and fusion of MPCs to a greater extent than in conventional monolayer
culture  [45].  Furthermore,  the  morphological  structure,  gene  expression  and  contractile
phenotype are also representative of in vivo skeletal muscle [43, 45, 67].
8 Alec S.T. Smith, Rishma Shah, Nigel P. Hunt, Mark P. Lewis. The Role of Connective Tissue and Extracellular Matrix
Signaling in Controlling Muscle Development, Function, and Response to Mechanical Forces. Seminars in orthodontics
1 June 2010 (volume 16 issue 2 Pages 135-142 DOI: 10.1053/j.sodo.2010.02.005)
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Figure 2. Biomimetic skeletal muscle constructs can be engineered from biological scaffolds. Example model of the
typical macroscopic contraction of a type-1 collagen matrix, following 14 days in culture. Note the custom made an‐
chors at either end, which provide predictable lines of longitudinal tension (illustrated by dashed arrows) to promote
cell alignment and fusion in a single plane. Scale bar = 10 mm.
A further advantage of using naturally derived polymers is the ability to easily stimulate, both
mechanically and electrically, due to the innate mechanical compliance of the polymerised
tissue. To this end, numerous investigations have employed such techniques to promote
myogenesis and maturation of seeded MPCs [65, 68, 69]. In contrast, the effect of a combined
mechanical stimulation protocol, contributed to a reduction in maturation of 3-D seeded
myogenic cells compared to monolayer controls [66]. Nevertheless, the effect of increased
mechanical signals for the promotion of MPC alignment and fusion, satisfies the desire for a
biomimetic.
Skeletal muscle in vivo is comprised of myogenic progenitors, non-myogeninc progenitors and
fibroblasts. The presence and influence of these non-myogenic populations has not been
widely investigated, however, there is evidence to suggest a potential synergistic role in the
development and maturation of skeletal muscle in vitro. The non-myogenic fibroblast popu‐
lation of cells has been shown to enhance skeletal muscle cell alignment, through contact
dependent and independent mechanisms [70]. Data from 3-D skeletal muscle constructs also
demonstrates an increased myogenin mRNA expression (marker of terminal differentiation)
and increased peak force in a heterogeneous mixture of myogenic and non-myogenic cells,
compared to myogenic only cultures [43]. Furthermore the expression of MMP-2 mRNA was
greater in the heterogeneous cell population cultures, suggestive of greater matrix remodelling
and fusion potential [43]. Together, these data illustrate the requirement of the non-myogenic
cell population to recapitulate the in vivo skeletal muscle cell niche and associated biological
processes. As such the incorporation of a heterogeneous population of cells should be utilised
when developing skeletal muscle models in vitro.
Consideration of the body of data discussed above, indicates that an argument can be made
that the ideal solution for a tissue engineered skeletal muscle construct would embrace the
following:
1. Appropriate matrix signals.
2. Induction of alignment.
3. Presence of other cell types.
4. Mechanical stimulation.
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Provision of all of the cues simultaneously requires an approach that moves beyond conven‐
tional monolayer models. The structure defines function in skeletal muscle in vivo and all of
the essential elements above can be combined using tissue engineering techniques. There are
a number of systems that have moved towards this aim, however important validations for
such systems is making comparisons against the in vivo tissue, physiological skeletal muscle.
The systems described have shown the following features to date:
Parameter Resemblance to In Vivo Tissue System and References
Passive longitudinal tension generated by
anchor points
Myotendinous junctions Collagen [43, 45, 53, 67, 68, 71];
Fibrin [53, 60, 65, 66]
ECM ECM protein composition Collagen [43, 45, 53, 67, 68, 71];
Fibrin [53]
Morphology of cells Alignment and fusion of seeded cells
in a single plane
Collagen [45, 53]; Fibrin [53, 66]
Active contractile phenotype (vector force) Excitability and contractility profile Fibrin [60, 62, 65];
Passive contractile phenotype (vector force) Cell-matrix passive contractile
interaction
Collagen [43, 45]
Myosin Heavy Chain (MYH) expression Increase in MYH-7 mRNA (slow
genotype)
Collagen [67]
Responses to stimulation (mechanical and
electrical)
Increases in gene and protein




Table 1. Comparison of current biomimetic skeletal muscle models of in vivo skeletal muscle tissue.
There can now be a high degree of confidence that the aforementioned systems do recreate a
significant aspect of in vivo skeletal muscle biology. Their use to-date with respect to providing
a pre-clinical test bed for exercise, genetic, pharmaceutical and nutritional therapies is limited,
however the system are now at a stage where such investigations are warranted.
5. Animal models of cartilage for arthritis research
Experimental models of degenerative joint diseases such as osteoarthritis (OA) and rheuma‐
toid arthritis (RA) have been in existence for several decades [72]. Animal models of arthritis
have been used to understand elements of the arthritic disease process in human patients [73].
They are powerful tools for studying pathologic changes in articular cartilage and bone in great
detail, and can be used to evaluate mechanisms of erosive processes [73]. Animal models of
arthritis are also used to evaluate potential anti-arthritic drugs for clinical use in human
patients [74-76]. The capacity for predicting efficacy in human disease is one of the most
important criteria in the selection of animal models [74]. The use of animals has been indis‐
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pensable to the investigation of the aetiology, pathophysiology, and treatment of various forms
of juvenile arthritis [77]. Animal models of rheumatoid arthritis (RA) are also well established
and have a proven track record of predictability [74, 78]. These include rat adjuvant arthritis
[79], rat and mouse type II collagen arthritis [80-82], and antigen-induced arthritis in several
species. Many animal species are currently used in OA research [83]. Figure 3 summarises the
main procedures and disadvantages of animal models of OA.
Figure 3. Procedures and major disadvantages of animal models of arthritis.
The animal models of OA include laboratory animals: mice, rats, guinea pigs, rabbits; farm
animals: sheep, goats; and companion animals: dogs, cats, horses. Animal models of OA
roughly fall into five categories; firstly, spontaneous OA, which naturally occurs in the knee
joints of animals, such as guinea pigs and dogs, and has a similar pathogenesis to human OA
[84, 85]. Secondly, the surgical creation of joint instability, for example anterior cruciate
ligament transection (ACLT) in dogs [86], meniscal tear model in rats [87], and collateral
ligament transection in horses [88]. Thirdly, the surgical replication of joint trauma, for
example the canine groove model [89], and carpal chip fragmentation in horses [90]. Fourthly,
injection into the joint, for example papain [91], sodium mono-iodoacetate [92] and collagenase
[93]. The final category is the knockout model, which deletes certain genes in mice resulting
in the development of OA-like degenerative joint disease. For example the deletion of genes
that code for type IX collagen [94], or the double deletion of biglycan and fibromodulin [95].
6. Biomimetic models of cartilage
Biomimetic models of articular cartilage were developed specifically for use in preclinical and
clinical research long before the advent of tissue engineering and regenerative medicine, and
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the realisation that the development of these models is an elementary form of tissue engineer‐
ing. One of the major advantages of articular cartilage is the fact that it is a relatively simple
tissue consisting of a fairly homogeneous extracellular matrix and a single cell type. Also,
cartilage is avascular, aneural and alymphatic [96, 97], a fact that was disputed for centuries
until modern histological techniques were applied to study the tissue [97]. This unique
property overcomes many of the obstacles that are involved in culturing other vascularised
and innervated tissues. The following sections will discuss the most popular 2- and 3-
dimensional models of cartilage.
6.1. 2-Dimensional monolayer models of chondrocyes
Two-dimensional in vitro models of chondrogenesis [98, 99] and methods for isolating and
cultivating primary bovine chondrocytes were established in the early 1960’s [100]. Methods
have been published for human [101] and rabbit [102] cartilage. Primary chondrocytes
[103-105] and SV-40 transformed chondrocyte-like cell lines [106] in monolayer culture are
routinely used for basic research [107]. These models have been useful for studying the cell
biology of cartilage and responses to drugs, pro-inflammatory cytokines, growth factors,
nutrients and nutraceuticals. Chondrocytes are also able to survive freezing and cryopreserved
cells retain the capacity to proliferate and synthesise ECM [108-111]. Although 2-D culture of
chondrocytes is widely used (see Figure 4), this method suffers from several major weaknesses:
1). The cells de-differentiate to fibroblast-like cells after 4-5 passages; 2] They do not synthesise
a genuine ECM. Early studies carried out in the 1960’s showed that high-density culture
preserves the chondrocyte phenotype; when cultured chondrocytes attain a certain cell density
they re-acquire their rounded shape, stop dividing, and re-synthesize collagens and proteo‐
glycans. Clusters of chondrocytes synthesize more proteoglycans than isolated chondrocytes
[112]. If chondrocytes are actively engaged in ECM synthesis they do not concurrently
synthesize DNA and so cannot divide and proliferate [112]. Interaction between chondrocytes
is important for maintaining ECM synthesis and failure of interaction between chondrocytes
leads to cell proliferation, a fact that has been exploited for expanding small numbers of
isolated chondrocytes from limited amounts of clinical material.
Although chondrocyte survival and phenotype are regulated by culture conditions, the
expression of the chondrogenic transcription factor Sox9 is of crucial importance [113]. The
unique phenotype of the chondrocyte requires sustained expression of Sox9. This transcription
factor plays an important role in the normal skeletal development and regulate the expression
of other genes involved in chondrogenesis [114, 115].
6.2. 3-Dimensional cartilage culture systems — Alginate beads
Alginic acid, also called algin or alginate, is an anionic polysaccharide that is widely distributed
in the cell walls of brown algae. When extracted in granular or powdered forms, alginate is
capable of absorbing 200-300 times its own weight in water. Due to its biocompatibility and
simple gelation with divalent cations such as Ca2+, alginate is widely used for cell immobili‐
zation and encapsulation. Therefore, alginate beads offer an ideal substrate for developing
support matrices for 3-dimensional chondrocyte culture (see Figure 5). Immobilization of cells
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along with macromolecules and biomaterials in alginate gels has become a well-established
technology. Alginate beads are used in many biomedical and industrial applications. Cells
immobilized in alginate gels maintain their differentiated phenotype during long-term culture
due to the 3-dimensional environment of the gel network. In tissue engineering applications
immobilized cells or tissue explants can be used as bioartificial organs as the alginate gel may
function as a protective barrier towards physical stress and to avoid immunological reactions
with the host. Chondrocytes can be encapsulated and maintained in calcium alginate beads or
gels in 3-dimensional culture [116]. Avian and mammalian chondrocytes cultured in "semi-
solid" and "hollow" alginate beads exhibit a spherical shape as opposed to the fibroblastic
morphology that is observed in monolayer culture [116]. The encapsulation methodology is
suitable for the culture of chondrocytes in single beads, in multiwell dishes, or mass culture.
Human and bovine adult articular chondrocytes have also been cultured in alginate beads and
studies have shown that they retain their spherical shape and typical chondrocyte-like
appearance for at least 5 weeks [117]. Alginate culture has also been used for cultivating
intervertebral disc cells [118], nucleus pulposus and annulus fibrosus cells [119] and chondro‐
cyte cell lines [120]. Aggrecan appears to be a major ECM molecule produced by alginate
cultured chondrocytes. Sensitive assays have been developed for the quantification of
glycosaminoglycans (GAGs) and nitric oxide (NO) produced by alginate cultures [121, 122].
Decorin is also synthesized in small amounts but it is rapidly lost from the agarose or alginate
gel [117]. Alginate culture can be used to induce the re-expression of cartilage-specific genes
(aggrecan and collagen II) by dedifferentiated human articular chondrocytes cultured in
Figure 4. Dimensional cultures of primary chondrocytes. This culture system is widely used for basic research on chon‐
drocyte biology and for drug toxicity testing.
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alginate beads. However, alginate is unable to restore the chondrocyte phenotype in SV-40
transformed cells [123]. Thus, articular chondrocytes embedded in alginate gel can produce
de novo a matrix rich in collagens and proteoglycans [124]. The alginate culture system appears
to represent a relevant model for maintaining primary populations of chondrocytes and
inducing the redifferentiation of dedifferentiated human chondrocytes, especially when they
have been expanded several times by passaging in monolayer culture. This approach is
particularly useful when small cartilage biopsies are available. New approaches to cartilage
tissue-engineering have combined isolated cells with polymer scaffolds (polyglycolic acid fibre
meshes and alginate gels) for the purpose of generating new cartilage (neo-cartilage) [125].
Figure 5. Chondrocyte culture in alginate beads.
6.3. 3–Dimensional cartilage culture systems — Agarose gels
Agar is a gelatinous substance derived from algae. It is a mixture of two components: the linear
polysaccharide agarose, and a heterogeneous mixture of smaller molecules called agaropectin.
Agar and agarose have been used extensively for cell culture. Agar gels are have been used
throughout the world to provide a solid surface containing medium for the growth of bacteria
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and fungi. As a gel, an agarose medium is porous and therefore can be used to re-create the 3-
dimensional environment that chondrocytes are accustomed to in articular cartilage. Culturing
chondrocytes in agarose gels is actually very similar to alginate beads. Agarose gels proved to
be particularly useful for studies on proteoglycans produced by avian [126], porcine [127] and
bovine [128] chondrocytes. Agarose gels re-create a biomimetic 3-dimensional environment
and stimulate ECM production by chondrocytes [129]. One of the most important studies on
chondrocyte differentiation and redifferentiation was done using agarose gels by Benya and
Shaffer [130]. As described earlier serial monolayer culture results in chondrocyte dedifferen‐
tiation and loss of phenotype. When chondrocytes dedifferentiate in monolayer culture they
stop producing proteoglycans and type II collagen and instead secrete a different ECM
consisting predominately of type I collagen and a low level of proteoglycan synthesis. Benya
and Shaffer used agarose gels to demonstrate that dedifferentiated chondrocytes re-express
the differentiated phenotype, producing proteoglycans and cartilage specific collagens [130].
The same outcome was achieved years later using alginate beads [131]. The original work of
Benya and Shaffer demonstrated that a complete return to the differentiated collagen and
proteoglycan producing chondrocyte phenotype is possible in agarose gels. Their results also
emphasized the essential role of the spherical cell shape in the modulation of the chondrocyte
phenotype and demonstrate a reversible system for the study of gene expression [130].
It is important to bear in mind that articular cartilage is subjected to dynamic compressive
loading during normal activity and this influences chondrocyte metabolism. Mechanical forces
are key determinants of connective tissue differentiation. Agarose gels, alginate beads and
other 3-D gel systems are well established for studying the effects of dynamic compression on
chondrocytes [132, 133]. These techniques have gained significant popularity over the last two
decades [134] and are still in use today to study patterns of gene expression in response to
dynamic compression [135] and chondrocyte mechanotransduction pathways [136]. The
preservation of the chondrocyte phenotype and the gradually increasing proteoglycan
synthesis in agarose and alginate gels are promising methods for creating and engineering
tissue implants for cartilage repair. These techniques can also be used to create new cartilage
tissue from the joints of food producing animals (i.e. cattle, sheep, pigs) without having to
sacrifice many smaller laboratory animals. This is an important area of cartilage tissue
engineering with important consequences for animal research.
6.4. 3-Dimensional cartilage explant culture
Explant culture is a technique used for the isolation of cells from a piece of tissue. Tissue
harvested in this manner is called an explant. The tissue is harvested under sterile conditions
and explants are placed in a cell culture dish containing growth media. In some explant
cultures (i.e. skeletal muscle) progenitor cells migrate out of the tissue and grow on the surface
of the dish. These primary cells can then be further expanded and exploited. In cartilage explant
culture cells remain in their surrounding extracellular matrix and this accurately mimics the
in vivo environment (see Figure 6). The method became established in the mid 1970’s [137,
138] and was used to study the effects of prostaglandins [139-141] and rheumatoid synovium
[142] on cartilage degeneration. The establishment of cartilage explant culture later became an
important prelude to the development of monolayer culture systems of chondrocytes [143].
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Cartilage Explant Culture 
 
 Cartilage is harvested from synovial 
under sterile conditions and pieces 
(explants) are placed in a culture 
dish containing growth media 
 
• Advantages of the Cartilage 
Explant Culture Model:  
– Cells remain in their 
original 3-dimensional 
environment 
– The extracellular matrix 
around them precisely 
mimics their in vivo 
environment 
– Ideal for studies of 
extracellular matrix 
synthesis and degradation  
– Suitable for proteomic work 
and studying anti-
inflammatory drugs and 
nutraceuticals 
Figure 6. Overview of cartilage explant culture and its unique advantages.
6.4.1. 3-Dimensional High-Density and Pellet Cultures of Chondrocytes
High-density culture is a 3-dimensional system that has been in the literature since the early
1970’s. High-density suspension cultures of chondrocytes were initially used to study cartilage
matrix protein synthesis by mammalian chondrocytes [144, 145], specifically mucoprotein
[146] and proteoglycan [147] biosynthesis. In an important study published in 1977 the method
was refined by von der Mark and von der Mark who used tissue culture plastic dishes on an
agar base to monitor chondrogenesis of stage-24 chick limb mesodermal cells in vitro by
analyzing the onset of type II collagen synthesis [148]. This work demonstrated that high-
density cultures may be used for the analysis of cell specific types of collagen and provide a
useful model for detailing the specific events in the differentiation of mesenchymal cells in
vitro. Several subsequent studies used chick limb bud mesenchymal cells and chick sternal
chondrocytes cultured in high-density to study chondrogenesis and proteoglycan synthesis
[149] and fibronectin expression [150]. We have successfully used this model as a model for
chondrogenic, osteogenic and tenogenic differentiation of mesenchymal stem cells and
redifferentiation of dedifferentiated chondrocytes [151-154].
The high-density model exhibits a number of characteristics that make it particularly suitable
for studies on chondrogenesis. In the first 24 hours of the high-density chondrocytes culture,
cells form prechondrogenic areas composed of densely packed cells with intercellular inter‐
actions (gap junctions); these are surrounded by a perichondrium of flat fibroblast-like cells
[155] resembling the situation during the early stage of chondrogenesis in vivo. The extensive
cell-cell interactions during the first step of chondrogenesis are crucial for cell aggregation
[156, 157]. The high-density culture system allows investigations during chondrogenesis
starting from early blastema/mesenchymal stem cell condensations until cartilage maturation.
This chondrogenic development is accompanied by enlargement of cartilage nodules, which
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is not due to cell proliferation but rather is due to appositional growth, which includes the
transition of perichondral cells into chondrocytes. These conclusions are based on the almost
complete absence of mitotic figures in cartilage and perichondrium and on the continuous
increase in nodule size during cultivation [156].
6.4.2. Co–cultures of chondrocytes and synoviocytes
The synovial joint contains several important tissue components. These are articular cartilage,
synovium, subchondral bone and fat pads (adipose tissue). Developing in vitro models that
include all of these tissues is a major challenge. Co-culture models involve growing distinct
cell types in a combined culture environment. The mixing of different cell types in culture is
normally avoided, although it is becoming increasingly apparent that this approach can be
used to model the cellular interactions that occur in vivo. Some studies of cellular interactions
may actually require direct cell-cell contact in a 2-dimensional model where two different cell
types are grown in mixture. Other studies may require proximity between the two cell types
without any actual cell-cell contact. In this scenario keeping the two types apart can allow
investigators to study the effect of one cell type on another. In a synoviocyte-chondrocyte co-
culture model synoviocytes grown on a filter insert may be stimulated with pro-inflammatory
cytokines or other inflammatory mediators (i.e. phorbol esters such as phorbol myristate
acetate (PMA), reactive oxygen species such as hydrogen peroxide or a combination of iron
and ascorbic acid to simulate inflammation-like radical attacks) before bringing the “activated”
cells in contact with chondrocytes. The use of cell culture inserts controls the physical contact
and also the duration of that contact. It is also possible to grow different cell types on either
side of the membrane, allowing a simulation of tissue behaviour to be built and studied. A co-
culture model of rat chondrocytes and a rabbit synoviocyte-like cell line (HIG-82, [158]), has
been used to show that chondrocytes establish protective mechanisms against reactive oxygen
species by interacting with synoviocytes [159]. This co-culture system presents a model to
study mechanisms of inflammation in articular joints under well-defined conditions [159].
With the financial support of the National Centre for the Replacement, Refinement and
Reduction of Animals in Research (NC3Rs) we have established a novel co-culture model of
primary equine synoviocytes and primary equine chondrocytes for using equine joints derived
from the abattoir9. We have not fully exploited this equine model system. However, since
chondrocytes and synoviocytes are the main cell types present in articular joints, such co-
culture models have been used for metabolic studies [160] and have the capacity to recapitulate
the inflammatory and catabolic events that occur in an arthritic joint.
7. Conclusions
Cell culture has a bright future. It is a fundamental and core component of tissue engineering
and regenerative medicine. In this context the majority of studies carried out to date have used
the well-established method of growing cells on 2-D plastic or glass substrates. There is
9 http://www.nc3rs.org.uk/researchportfolio/showcatportfolio.asp?id=254
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increasing use of 3-D cell cultures in research areas as diverse as drug discovery, cancer
biology, regenerative medicine and basic life science research. There are many methods to
facilitate the growth of 3-D cellular structures including nanoparticle facilitated magnetic
levitation, gels, beads and solid matrices, self-assembling scaffolds and hanging drop plates.
The culture of mammalian cells for toxicity testing or drug screening is likely to increase in the
future. The biotechnology, pharmaceutical and cosmetic industries urgently need 3-D cell
culture models that more accurately mimic living tissues and organs. This kind of technology
will gradually increase in importance because of the vast array of natural and combinatorial
products that require screening and the increased pressure from regulatory authorities to
reduce animal testing. Most importantly, the pressure to reduce animal testing will stimulate
scientists to create more robust biomimetic culture models and culture systems that may
eventually eliminate the need for using animals for antibody production and vaccine devel‐
opment. There are many exciting and emerging areas that have not been reviewed in this
chapter. This chapter has focused on biomimetic models of joint and muscle. Since joint tissues
contain a diverse number of cell types, we have focused our efforts on in vitro models of
chondrocytes and skeletal muscle cells.
It is becoming clear that OA is a disease of the entire joint rather than any single component
and deterioration of associated skeletal muscle masses around an affected joint is a well-
reported phenomena. Changes in the highly adaptive skeletal muscle may precede changes
seen in other tissue types so analysis of the transcriptome/metabolome could have great value
in prognosis and diagnosis. It is possible to conduct such studies in humans although such
experiments are logistically complicated, requiring appropriate subject numbers that adhere
to complicated inclusion and exclusion criteria and expensive consumables. It could however
be argued that a more beneficial approach would be to utilise a “pre-clinical model” to further
refine and develop hypotheses before introduction in the human being. This approach would
clearly also decrease the need for animal work.
A number of animal models of arthritis have been developed to study arthritic disease
pathogenesis and evaluate the efficacy of candidate anti-inflammatory and anti-arthritic drugs
for clinical development [161-167]. These animal models may involve injection of inflamma‐
tory agents into the joint, surgical creation of joint instability or surgical replication of joint
trauma. Such models not only cause a considerable amount of pain and suffering but also none
of them have a proven track record of predictability in human disease. Consequently, there is
an acute need for developing novel and alternative in vitro models that mimic the biology of
cartilage [168-172]. Many studies have used articular cartilage and synovial tissues to establish
in vitro models of the joint. In our laboratories we have developed explant models of articular
cartilage inflammation, co-cultures of primary synoviocytes and chondrocytes as well as 3-
dimensional high-density cultures of chondrocytes and MSCs [152, 153, 173-175]. We have also
determined the potential of phytochemicals as stimulators of chondrogenic differentiation.
These culture models of MSCs, fully differentiated cells and co-cultures have potential as
‘‘proof of principle’’ ethically acceptable ‘‘3Rs’’ models for engineering biomimetic models of
articular cartilage in vitro for the purpose of replacing and reducing the use of animals in
arthritis research. This approach could help reduce the number of laboratory animals used in
arthritis research and may provide a realistic alternative to experimental animals.
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Articular cartilage damage is a persistent and increasing problem as the ageing population
expands and treatments to achieve biological repair have been challenging [176]. Cartilage
tissue engineering has been around for over 20 years. However, none of the approaches
available so far have been able to achieve the consistency, effectiveness and reliability that are
required for clinical applications. Tissue engineering of a mechanically resilient cartilage
construct that meets the structural and functional criteria for effective functional integration
into a defect site in the host is a difficult endeavour [177]. One of the fundamental weaknesses
of all the models available to date is that none of them possess the normal zonal organization
of chondrocytes that is seen in vivo (i.e. superficial, middle, deep and calcified zones) and the
local composition of extracellular matrix in each zone. This structural organisation is a pre-
requisite for normal cartilage function and the success of any future clinical applications. The
currently available 3-D models produce fairly homogeneous populations of cells without the
ability to achieve any zonal organization in vitro [176]. The ability to produce a construct that
recapitulates the zonal and structural architecture of the original tissue is currently lacking.
Even the mechanically stable scaffolds that have been created so far do not allow regeneration
of a sufficiently large mass of structurally and functionally competent cartilage construct
especially if they were constructed and seeded with 2-D passaged (monolayer) chondrocytes
in combination with a biomimetic carrier or scaffold [177]. This is one reason why future
studies must begin with 3-D cultured chondrocytes maintained in a physiologically relevant
microenvironment that replicates the ionic, osmotic and biomechanical milieu of cartilage. The
3-D and microenvironmental impact on cell phenotype is a significant factor creating cartilage
constructs within biomimetic scaffold constructs [177].
In summary, it may be difficult to imagine research being done without animal models but it
is worth pointing out that in vitro models of joint and musculoskeletal tissues have been around
for several decades and new researchers are increasingly adopting them for work on muscu‐
loskeletal diseases. Therefore, it is our optimistic view that in future many animal models could
potentially be replaced with biomimetic and animal sparing alternatives in a variety of research
disciplines and applications.
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